Sartorius AG (ADR)
General ticker "SSSGY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $13.6B (TTM average)
Sartorius AG (ADR) follows the US Stock Market performance with the rate: 1.3%.
Estimated limits based on current volatility of 0.0%: low 43.33$, high 43.33$
Factors to consider:
- Company pays dividends (annually): last record date 2025-03-31, amount 0.08$ (Y0.18%)
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [27.78$, 53.37$]
- 2025-12-31 to 2026-12-31 estimated range: [26.13$, 50.32$]
Financial Metrics affecting the SSSGY estimates:
- Positive: with PPE of 107.4 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 12.93
- Positive: 6.82 < Operating cash flow per share per price, % of 7.85
- Negative: Industry inventory ratio change (median), % of 1.55 > 0.28
- Negative: Industry operating cash flow per share per price (median), % of 0.78 <= 5.52
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Investing cash flow per share per price, % of -3.42 <= -0.66
- Positive: -8.75 < Industry operating profit margin (median), % of -7.19
Short-term SSSGY quotes
Long-term SSSGY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €4,174.70MM | €3,395.70MM | €3,380.70MM |
| Operating Expenses | €3,038.80MM | €2,852.50MM | €2,943.50MM |
| Operating Income | €1,135.90MM | €543.20MM | €437.20MM |
| Non-Operating Income | €45.80MM | €-157.20MM | €-250.40MM |
| Interest Expense | €35.20MM | €144.90MM | €205.40MM |
| R&D Expense | €177.80MM | €170.80MM | €196.80MM |
| Income(Loss) | €1,181.70MM | €386.00MM | €186.80MM |
| Taxes | €0.00MM | €95.90MM | €49.40MM |
| Profit(Loss)* | €913.10MM | €205.20MM | €84.00MM |
| Stockholders Equity | €1,989.80MM | €2,067.30MM | €2,764.80MM |
| Inventory | €1,179.10MM | €1,036.70MM | €788.50MM |
| Assets | €6,977.70MM | €9,755.30MM | €10,103.00MM |
| Operating Cash Flow | €734.20MM | €853.60MM | €976.20MM |
| Capital expenditure | €522.60MM | €559.70MM | €409.90MM |
| Investing Cash Flow | €-1,129.90MM | €-2,823.30MM | €-425.80MM |
| Financing Cash Flow | €209.90MM | €2,165.70MM | €-128.30MM |
| Earnings Per Share** | €2.67 | €0.60 | €0.24 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.